Rocket Pharmaceuticals, Inc. - stock earnings
RCKT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -59.7 million USD | 10.3 million USD |
| 2023Q3 | -61.9 million USD | ? USD |
| 2023Q2 | -65.7 million USD | ? USD |
| 2023Q1 | -54.9 million USD | ? USD |
| 2022Q4 | -64.4 million USD | ? USD |
| 2022Q3 | -57.0 million USD | ? USD |
| 2022Q2 | -54.6 million USD | ? USD |
| 2022Q1 | -43.4 million USD | ? USD |
| 2021Q4 | -44.2 million USD | ? USD |
| 2021Q3 | -50.1 million USD | ? USD |
| 2021Q2 | -34.5 million USD | ? USD |
| 2021Q1 | -40.2 million USD | ? USD |
| 2020Q4 | -60.9 million USD | ? USD |
| 2020Q3 | -29.1 million USD | ? USD |
| 2020Q2 | -25.0 million USD | ? USD |
| 2020Q1 | -24.7 million USD | ? USD |
| 2019Q4 | -19.9 million USD | ? USD |
| 2019Q3 | -19.3 million USD | ? USD |
| 2019Q2 | -18.7 million USD | ? USD |
| 2019Q1 | -19.5 million USD | ? USD |
| 2018Q4 | -27.3 million USD | ? USD |
| 2018Q3 | -16.1 million USD | ? USD |
| 2018Q2 | -15.8 million USD | ? USD |
| 2018Q1 | -15.3 million USD | ? USD |
| 2017Q4 | -4.9 million USD | ? USD |
| 2017Q3 | -7.4 million USD | ? USD |
| 2017Q2 | -6.6 million USD | ? USD |
| 2017Q1 | -10.7 million USD | ? USD |
| 2016Q4 | -13.0 million USD | ? USD |
| 2016Q3 | -11.1 million USD | ? USD |
| 2016Q2 | -8.7 million USD | ? USD |
| 2016Q1 | -10.1 million USD | ? USD |
| 2015Q4 | -8.2 million USD | ? USD |
| 2015Q3 | -56.0 million USD | ? USD |
| 2015Q2 | -2.4 million USD | ? USD |
| 2015Q1 | -1.5 million USD | ? USD |
| 2014Q4 | -2.1 million USD | ? USD |
| 2014Q3 | -2.4 million USD | ? USD |
| 2014Q2 | -2.8 million USD | ? USD |
| 2014Q1 | -2.1 million USD | ? USD |
| 2013Q4 | -2.0 million USD | ? USD |
RCKT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -245.6 million USD | ? USD |
| 2022 | -219.4 million USD | ? USD |
| 2021 | -169.6 million USD | ? USD |
| 2020 | -146.7 million USD | ? USD |
| 2019 | -83.2 million USD | ? USD |
| 2018 | -74.5 million USD | ? USD |
| 2017 | -29.5 million USD | ? USD |
| 2016 | -42.9 million USD | ? USD |
| 2015 | -68.0 million USD | ? USD |
| 2014 | -9.5 million USD | ? USD |
| 2013 | -7.6 million USD | ? USD |
| 2012 | -6.1 million USD | ? USD |
RCKT
Price: $23.20
52 week price:
Earnings Per Share: -2.92 USD
P/E Ratio: -9.06
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 607900
Market Capitalization: 2.2 billion